论文部分内容阅读
目的:探讨前列腺增生患者年龄,前列腺体积以及BMI与血清前列腺特异性抗原(PSA)之间的关系。方法:对224例前列腺增生患者的年龄,前列腺体积以BMI与PSA的相关性进行Spearman相关性分析。结果:224例前列腺增生患者有25%的患者PSA水平高于正常,并且年龄,前列腺体积与血清PSA存在明显的正相关:(r=0.672.P<0.01,r=0.785.P<0.01),而血清PSA与BMI指数存在明显的负相关:(r=-0.873,P<0.01)。结论:前列腺增生患者的血清PSA值随患者年龄增长和体积增大而增加,对于PSA轻度升高的前列腺增生患者,要考率到体重因素对结果的影响。
Objective: To investigate the relationship between age, prostate volume and BMI in patients with benign prostatic hyperplasia (BPH) and serum PSA (prostate specific antigen). Methods: Spearman correlation analysis was performed on the correlation between BMI and PSA in 224 patients with BPH and age and prostate volume. Results: The PSA level was higher than normal in 25% of 224 BPH patients, and there was a significant positive correlation between age and prostate volume and serum PSA (r = 0.672 P <0.01, r = 0.785.P <0.01) There was a significant negative correlation between serum PSA and BMI (r = -0.873, P <0.01). Conclusion: The serum PSA level of BPH patients increases with age and volume of patients. For patients with prostatic hyperplasia with mild PSA, the impact of body weight on the outcome should be investigated.